Cancer News: Prostate

Active surveillance shows real promise in prostate cancer

Prostate cancer patients with relatively unaggressive tumors survived without surgery or radiation, due to an active surveillance program, a new study proves.

Combination therapy improves survival in metastatic prostate cancer

Newly diagnosed patients with metastatic, hormone-sensitive prostate cancer survived longer when treated with a combination of two drugs, a new study reveals.

Updates on radiation therapy for prostate cancer patients

Increased radiation dose did not benefit low-risk prostate cancer patients, while it raised survival rates in medium and high-risk prostate cancer patients.

Fewer side effects for prostate cancer with alternative approach

Watchful waiting or active surveillance may provide an alternative to prostate cancers patients keeping them away from the side effects of aggressive treatments.

Adjuvant chemotherapy improves survival in prostate cancer patients

The combination of adjuvant chemotherapy with androgen suppression and definitive radiation therapy extended overall survival in patients with high-risk prostate cancer.

Obesity linked with worse localized prostate cancer outcomes

An increasing body mass index (BMI) was associated with worse prostate cancer-specific outcomes in patients with localized prostate cancer, a new study reveals.

Genetic factors linked to the hot flashes of prostate cancer patients

Age and body mass index and other gene factors associated with the hot flashes, men with prostate cancer experience when treated with androgen deprivation therapy.

Gastrointestinal tumors associated with higher cancer risk

Patients with gastrointestinal stromal tumors may develop additional malignancies before and after their diagnosis, according to the first population-based study.

Radiotherapy method doubles likelihood of prostate cancer remission

Prostate cancer patients who receive permanent brachytherapy implants are twice as likely to be cancer-free after 5 years compared to external radiation.

Positive results for olaparib in men with metastatic prostate cancer

Men with prostate cancer that had mutations in genes linked to repair of damaged DNA responded better to treatment with olaparib compared with patients who had disease without these mutations.

Walking benefits prostate cancer patients after treatment

A new study shows that walking at an easy pace for only 3 hours every week is enough to help reduce the side effects of prostate cancer treatment.

New data on radiation overturns prostate cancer treatment approach

Findings of two clinical trials overturn the widely accepted tactic of delaying radiation treatment to prostate cancer patients in order to reduce side effects.

Conservative treatment: a better option for some prostate cancer patients

Results from a population-based study show favorable survival outcomes among older patients with low-risk prostate cancer treated with conservative management.

Vitamin D as an alternative to surgery/radiation in prostate cancer

Vitamin D can fight inflammation and improve the tumors of prostate cancer patients reducing the need for surgery or radiation, according to scientists.

Yet another reason for prostate cancer patients to quit smoking

Prostate cancer patients who smoke or have quit smoking less than 10 years previously, have twice the risk of a recurrence after surgery, according to new research.

A familial connection between breast and prostate cancer

Having first-degree relatives with a history of prostate cancer increases a woman’s risk of developing breast cancer, according to a new study.

Prostate cancer: news on treatment and control options

Numerous latest findings in prostate cancer care were presented at the Genitourinary Cancers Symposium.

Men who have had testicular cancer at higher risk of prostate cancer

A study of 180,000 men indicates that men with history of testicular cancer have much higher risk of prostate cancer.

Perils of active surveillance on intermediate-risk prostate cancer

Men with intermediate-risk prostate cancer under active surveillance had significantly worse outcomes compared to those with low risk, according to a study.

Earlier, intense radiation after prostatectomy benefits patients

Prostate cancer patients with detectable prostate specific antigen (PSA) after radical prostatectomy should receive earlier, more aggressive radiation treatment.

Prostate cancer drug proven beneficial if taken before chemotherapy

Prostate cancer drug abiraterone was found to significantly extend the lives of men with advanced prostate cancer if given before chemotherapy, in a trial.

Smoking and prostate cancer: a dangerous combination

Smokers with prostate cancer face increased risks of experiencing side effects from treatment and of developing future cancer recurrences.

A more reliable diagnostic tool in prostate cancer

Targeted MRI/ultrasound has been found to be more effective than standard biopsy in detecting high-risk prostate cancer in a large scale study.

Could testosterone shrink advanced prostate tumors?

In a surprising paradox during a trial, testosterone, generally thought to be a feeder of prostate cancer, was found to suppress some advanced prostate cancers.

Sipuleucel-T in prostate cancer: More harm than good

Evaluating Sipuleucel-T, a prostate cancer drug, did not show proof of benefit in overall survival or patients’ health-related quality of life.

Prolonged survival for older men with prostate cancer

Hormone therapy plus radiation reduced cancer deaths by nearly 50% in older men with prostate cancer compared to patients who received hormone therapy alone.

Exercise and active lifestyle help prostate cancer survival

A new study shows that prostate cancer patients with active lifestyles have better survival rate: walking or biking for 20+ minutes a day can make a difference.

Prostate cancer patients monitoring their disease have high quality of life

In an analysis, patients who decide to monitor their prostate cancer with their doctors have equal/better wellbeing, compared to those who treat it immediately.

Prostate cancer: high cholesterol, triglycerides may raise recurrence risk

According to a new study, survivors of prostate cancer with higher levels of total cholesterol and triglycerides had an increased risk for disease recurrence.

The impact of prostate cancer treatments on urinary and sexual functioning

Researchers analyzed the impact of prostate cancer treatment on urinary and sexual functioning to understand how each different option affects patients.

Login to your account

Did you forget your password?